Filing Details
- Accession Number:
- 0001193805-20-000133
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-11 10:16:53
- Reporting Period:
- 2020-02-11
- Accepted Time:
- 2020-02-11 10:16:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1368514 | Adma Biologics Inc. | ADMA | Biological Products, (No Disgnostic Substances) (2836) | 562590442 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1554537 | James Mond | C/O Adma Biologics, Inc. 465 State Route 17 Ramsey NJ 07446 | Cso And Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-02-11 | 4,285 | $3.50 | 22,174 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Represents a purchase from the underwriters in the Issuer's public offering.